MedPath
HSA Approval

RESOLVE PLUS 1.0

SIN11900P

RESOLVE PLUS 1.0

RESOLVE PLUS 1.0

April 26, 2002

EGO PHARMACEUTICALS (SINGAPORE) PTE. LTD.

EGO PHARMACEUTICALS (SINGAPORE) PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantEGO PHARMACEUTICALS (SINGAPORE) PTE. LTD.
Licence HolderEGO PHARMACEUTICALS (SINGAPORE) PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

CREAM

TOPICAL

Medical Information

D01AC52

miconazole, combinations

Manufacturer Information

EGO PHARMACEUTICALS (SINGAPORE) PTE. LTD.

EGO PHARMACEUTICALS PTY LTD

Active Ingredients

MICONAZOLE NITRATE

2% w/w

Miconazole

HYDROCORTISONE

1% w/w

Hydrocortisone

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

RESOLVE PLUS 1.0 - HSA Approval | MedPath